Three Ring is a technology company.
Three Ring has raised $2.5M across 2 funding rounds.
Three Ring has raised $2.5M in total across 2 funding rounds.
# Triple Ring Technologies: A Deep-Tech Co-Development Platform
Triple Ring Technologies is a corporate growth lab that partners with medtech and life sciences companies to accelerate innovation, manage R&D risk, and bring breakthrough technologies to market.[1][4] Founded in 2005 and headquartered in Newark, California, the company operates as a trusted intermediary between large corporations, startups, and global innovation ecosystems, positioning itself at the intersection of deep-tech development and strategic commercialization.
Triple Ring functions as a co-development partner rather than a traditional consultant, structuring projects to share risk with clients while delivering tangible innovation outcomes.[4] The company serves medtech and life sciences corporations alongside select startups, helping them navigate the "innovator's dilemma" by strengthening mid-term product pipelines, accelerating time to market, and creatively managing R&D expenses.[1][4]
The firm's core value proposition centers on multidisciplinary expertise spanning early R&D, product development, manufacturing, regulatory approval, and market access.[2] With over 100 technologists and experts, Triple Ring brings domain depth in surgery, cardiology, neurology, and drug discovery, complemented by venture-building experience and in-house incubation facilities.[4] The company operates offices in Boston, Toronto, and Copenhagen alongside its Silicon Valley headquarters, enabling it to serve both North American and international clients.[2]
Triple Ring was established in 2005 as a response to a specific market gap: large medtech and life sciences corporations needed a flexible, specialized partner to handle high-risk R&D without the overhead of permanent headcount expansion.[1][4] The company's founding reflected a recognition that breakthrough innovation in healthcare required not just technical capability, but also commercialization expertise and the ability to bridge laboratory discoveries with clinical and market realities.
Over two decades, Triple Ring evolved from a product development shop into what it now describes as a "strategic hub for innovation diplomacy"—a convening platform that connects global governments, corporations, and startups around shared scientific challenges.[1] This evolution accelerated notably in 2025, when the company expanded its international programming and positioned itself as a neutral intermediary between global innovation agencies and U.S. markets.[1]
Triple Ring operates at the intersection of two major trends: the acceleration of deep-tech commercialization and the rise of innovation diplomacy as a strategic priority for governments and corporations.
The company benefits from sustained investment in medtech and life sciences innovation, where the complexity and regulatory burden create persistent demand for specialized co-development partners.[4] Simultaneously, geopolitical factors—including efforts by multiple countries to strengthen innovation ecosystems and secure strategic partnerships—have elevated Triple Ring's role as a convening platform.[1] By positioning itself as a neutral intermediary, the company captures value from the growing recognition that breakthrough innovation increasingly requires cross-border collaboration and ecosystem-level coordination rather than siloed corporate R&D.
Triple Ring's influence extends beyond individual projects: it shapes how large corporations approach innovation risk, demonstrates viable models for venture-building within corporate structures, and creates infrastructure for the kind of international scientific collaboration that governments increasingly prioritize.
Triple Ring is well-positioned to expand its influence as medtech and life sciences companies face mounting pressure to innovate faster while managing capital constraints. The company's 2025 expansion into international programming and bilateral partnerships signals confidence in a future where innovation diplomacy becomes a core business function rather than a peripheral activity.
The key question ahead is whether Triple Ring can scale its convening and intermediary role without diluting the technical depth that makes it credible to both corporations and startups. As it deepens partnerships across Asia, Europe, and North America, the company's ability to maintain neutrality while driving commercial outcomes will determine whether it becomes a defining platform for 21st-century deep-tech innovation or remains a specialized service provider to a niche market.[1]
Three Ring has raised $2.5M in total across 2 funding rounds.
Three Ring's investors include Bonsal Capital, Great Oaks Venture Capital, Ben Lin, Dan Ciporin.
Three Ring has raised $2.5M across 2 funding rounds. Most recently, it raised $2.0M Series A in September 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2014 | $2.0M Series A | Bonsal Capital | |
| Nov 1, 2013 | $530K Seed | Great Oaks Venture Capital, Ben Lin, Dan Ciporin |